Association for Molecular Pathology                       
Newsletter                                                                
   
May 2009, Volume 15, Number 2 

Inside this Issue

Front Page
President's Message
Committee Reports
• Clinical Practice Committee
 Economic Affairs Committee
 Membership & Professional
  Development Committee

 Nominating Committee
 Professional Relations Committee
 Program Committee
 Publications Committee
 Training & Education Committee
Subdivision Reports
 Genetics
 Hematopathology
 Infectious Diseases
 Solid Tumors
Special Features
 AMP Leadership Award
 CHAMP

 Member Survey Report
 Web Editorial Board Report
 Show Me the Money!
 Announcements
 Career Opportunities
 Meetings and Upcoming Events
2009 AMP Officers and Appointees

Solid Tumors Subdivision Report

Antonia R. Sepulveda MD, PhD


By Antonia R. Sepulveda MD., PhD.
Chair, Solid Tumors Subdivision
e-mail: Sepulveda@uphs.upenn.edu

 

This year, 2009, continues to affirm the vibrant field of molecular testing of solid tumors as a rapidly expanding field, now claiming a long list of tests used in routine clinical testing. This year, heading the new armamentarium of molecular tests for solid tumors are applications of predictive tumor marker for treatment selection.

The 2009 Program Committee Representatives Antonia Sepulveda and Loren Joseph working with the Program Committee have put together what we feel is an exciting Annual Meeting Program for the AMP membership. Here are some highlights. The program will feature state of the art advances in the application of molecular testing for the selection of cancer therapies, including talks covering Kras mutation testing. The advances from the human genome project have had very significant effects in the development of our field of Molecular Pathology and Diagnostics and this year, we will feature speakers who are investigators and practicing molecular pathologists who will present advances made possible by the human genome initiative and The Cancer Genome Atlas (TCGA) program. Similar to last year, the program will include a platform presentation Workshop Session featuring oral presentations selected from the submitted abstracts.

Representatives to the Training and Education (T&E) Committee, Jennifer Laudadio and Liang Cheng have worked with the T&E Committee on the development of four webinars to be presented in 2009 including one focusing on solid tumors. As part of the webinar series, the Training and Education Committee is hosting a Spring webinar on testing for tumors of unknown origin.   This Committee began planning for the annual outreach course and is looking to include more solid tumor/anatomic pathology topics this year. Nominating Committee Representatives for the Solid Tumor Subdivision, Marina Nikiforova and Deborah Dillon have been active in recruiting candidates for the Solid Tumor Subdivision for the upcoming election.

From the Clinical Practice Committee (CPC), Bill Funkhouser and Frederico Monzon are working on a review manuscript of the impact of fixation on molecular testing.  Frederico is also working on a hybrid CPC/PRC workgroup that is crafting a letter to FDA expressing AMP's position on Genentech's petition to regulate Laboratory Developed Tests (LDT). 

Abstract submission is open until the deadline June 2, 2009. Go Solid Tumors Subdivision (STS)! Let's have a record number of abstracts this year! 

Wishes for a wonderful Spring to all of you.